Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Harpoon Therapeutics Inc (HARP)
NASDAQ:HARP
RESEARCH TOOLSreports
Holding HARP?
Track your performance easily
HARP Stock Chart & Stats
Day’s Range$22.99 - $23.02
52-Week Range― - ―
Previous Close$22.99
Volume6.62M
Average Volume (3M)N/A
Market Cap
$492.35M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$23.50Price Target Upside2.13% Upside
Rating ConsensusHold
Number of Analyst Covering9
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
HARP FAQ
What was Harpoon Therapeutics Inc’s price range in the past 12 months?
Currently, no data Available
What is Harpoon Therapeutics Inc’s market cap?
Currently, no data Available
When is Harpoon Therapeutics Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Harpoon Therapeutics Inc’s earnings last quarter?
Currently, no data Available
Is Harpoon Therapeutics Inc overvalued?
According to Wall Street analysts Harpoon Therapeutics Inc’s price is currently Undervalued.
Does Harpoon Therapeutics Inc pay dividends?
Harpoon Therapeutics Inc does not currently pay dividends.
What is Harpoon Therapeutics Inc’s EPS estimate?
Harpoon Therapeutics Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Harpoon Therapeutics Inc have?
Currently, no data Available
What happened to Harpoon Therapeutics Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Harpoon Therapeutics Inc?
Among the largest hedge funds holding Harpoon Therapeutics Inc’s share is New Leaf Venture Partners, L.L.C.. It holds Harpoon Therapeutics Inc’s shares valued at 21M.
---
Harpoon Therapeutics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$23.50 (2.13% Upside)
$23.50 (2.13% Upside)
Blogger Sentiment
Bullish
HARP Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 3.9M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Negative
Last 7 Days ▼ 2.8%
Last 30 Days ▲ 1.5%
Last 30 Days ▲ 1.5%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
243.43%
12-Months-Change
Fundamentals
Return on Equity
-284.33%
Trailing 12-Months
Asset Growth
-43.02%
Trailing 12-Months
Company Description
Harpoon Therapeutics Inc
Harpoon Therapeutics, Inc. is a clinical-stage immunotherapy company, which develops a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases. It offers Tri-specific T cell Activating Construct (TriTACs) that focuses on the treatment of solid tumors and hematologic malignancies. The company founded by Patrick A. Baeuerle, Luke B. Evnin, and Jeanmarie Guenot on March 19, 2015 and is headquartered in South San Francisco, CA.
---
HARP Stock 12 Month Forecast
Average Price Target
$23.50
▲(2.13% Upside)
Technical Analysis
Abeona Therapeutics
―
Adverum Biotechnologies
―
Arrowhead Pharmaceuticals
―
Bluebird Bio
―
Best Analysts Covering HARP
1 Year
1 Year Success Rate
1/6 ratings generated profit
1 Year Average Return
-27.27%
reiterated a buy rating 2 years ago
Copying Joseph Catanzaro's trades and holding each position for 1 Year would result in 16.67% of your transactions generating a profit, with an average return of -27.27% per trade.
---